BioWorld Science

March 17, 1997

View Archived Issues

Draxis to promote dermatological drug in Canada

Read More

OXiGENE reports favorable preclinical results with Neu-Sensamide and Oxi-104

Read More

FDA approval for first-ever home test for use with oral anticoagulant therapy

Read More

Creative BioMolecules reports 1996 year-end results

Read More

British Biotech announces three-month financial results

Read More

Atrix Laboratories announces 1996 year-end results

Read More

Major growth in R&D activities in first quarter of 1997 for DiagnoCure

Read More

Alteon announces financial results for the fiscal year

Read More

Genzyme General's fourth-quarter EPS was $0.29 before acquisition charges

Read More

NeXstar Pharmaceuticals announces 1996 and fourth-quarter results

Read More

Cypros Pharmaceutical reports second-quarter and six-month results

Read More

Genzyme Transgenics and Fresenius to further development of transgenic albumin

Read More

BioChem Pharma creates new subsidiary to manage venture capital for genomic research

Read More

Positive clinical trial results for CDP-571 in Crohn's disease

Read More

Potent, nonselective adenosine agonist from Schering-Plough

Read More

Ritonavir approved for pediatric use in U.S.

Read More

Repeated IVIg for relapsing-remitting MS

Read More

FDA approves Viracept for adult and pediatric use

Read More

SIB-1508Y associated with improvement in cognitive deficits in Parkinson's model

Read More

Osiris Therapeutics awarded SBIR grant for tendon regeneration research

Read More

Astra gains European approval of asthma treatment

Read More

Biora establishes subsidiary in Italy

Read More

ProCyte's hair transplant wound dressing approved by FDA

Read More

Aricept cleared for marketing in U.K.

Read More

New therapy for essential tremor recommended for approval

Read More